Iovance Biotherapeutics, Inc. (IOVA)
2.53
+0.17
(+7.20%)
USD |
NASDAQ |
Feb 06, 16:00
2.56
+0.03
(+1.19%)
After-Hours: 20:00
Iovance Biotherapeutics Total Assets (Quarterly) : 904.95M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Lantheus Holdings, Inc. | 2.276B |
| Plus Therapeutics, Inc. | 18.67M |
| BioStem Technologies, Inc. | 62.39M |
| Protokinetix, Inc. | 0.4776M |
| GB Sciences, Inc. | 0.0945M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 202.66M |
| Shareholders Equity (Quarterly) | 702.29M |
| Debt to Equity Ratio | 0.0747 |
| Current Ratio | 3.411 |
| Net Debt Paydown Yield | 0.70% |